Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


VMD making headway with 3Rs concept

Historically, challenge tests with lethal endpoints have been used to assess batch potency testing for some vaccines such as rabies, leptospira, clostridial and various fish vaccines. Serological and/or in vitro alternative methods have been developed and implemented for some vaccines. However, some vaccines in these categories still rely on the challenge test. The London-based Veterinary Medicines Directorate (VMD) has questioned why this is the case.


What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts